Product Details for NDA 020929
PULMICORT RESPULES (BUDESONIDE)
0.25MG/2ML
Marketing Status: Prescription
0.5MG/2ML
Marketing Status: Prescription
1MG/2ML
Marketing Status: Prescription
0.25MG/2ML
Marketing Status: Prescription
Active Ingredient: BUDESONIDE
Proprietary Name: PULMICORT RESPULES
Dosage Form; Route of Administration: SUSPENSION; INHALATION
Strength: 0.25MG/2ML
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AN
Application Number: N020929
Product Number: 001
Approval Date: Aug 8, 2000
Applicant Holder Full Name: ASTRAZENECA PHARMACEUTICALS LP
Marketing Status: Prescription
Patent and Exclusivity Information
PULMICORT RESPULES (BUDESONIDE)
Proprietary Name: PULMICORT RESPULES
Dosage Form; Route of Administration: SUSPENSION; INHALATION
Strength: 0.25MG/2ML
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AN
Application Number: N020929
Product Number: 001
Approval Date: Aug 8, 2000
Applicant Holder Full Name: ASTRAZENECA PHARMACEUTICALS LP
Marketing Status: Prescription
Patent and Exclusivity Information
0.5MG/2ML
Marketing Status: Prescription
Active Ingredient: BUDESONIDE
Proprietary Name: PULMICORT RESPULES
Dosage Form; Route of Administration: SUSPENSION; INHALATION
Strength: 0.5MG/2ML
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AN
Application Number: N020929
Product Number: 002
Approval Date: Aug 8, 2000
Applicant Holder Full Name: ASTRAZENECA PHARMACEUTICALS LP
Marketing Status: Prescription
Patent and Exclusivity Information
PULMICORT RESPULES (BUDESONIDE)
Proprietary Name: PULMICORT RESPULES
Dosage Form; Route of Administration: SUSPENSION; INHALATION
Strength: 0.5MG/2ML
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AN
Application Number: N020929
Product Number: 002
Approval Date: Aug 8, 2000
Applicant Holder Full Name: ASTRAZENECA PHARMACEUTICALS LP
Marketing Status: Prescription
Patent and Exclusivity Information
1MG/2ML
Marketing Status: Prescription
Active Ingredient: BUDESONIDE
Proprietary Name: PULMICORT RESPULES
Dosage Form; Route of Administration: SUSPENSION; INHALATION
Strength: 1MG/2ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AN
Application Number: N020929
Product Number: 003
Approval Date: Aug 8, 2000
Applicant Holder Full Name: ASTRAZENECA PHARMACEUTICALS LP
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: PULMICORT RESPULES
Dosage Form; Route of Administration: SUSPENSION; INHALATION
Strength: 1MG/2ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AN
Application Number: N020929
Product Number: 003
Approval Date: Aug 8, 2000
Applicant Holder Full Name: ASTRAZENECA PHARMACEUTICALS LP
Marketing Status: Prescription
Patent and Exclusivity Information